Skip to main content
NewslettersWatchlist

Moderna Inc(MRNA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low122.59
Day High126.40
Open:125.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Nasdaq Futures Climb on Upbeat Apple Results, U.S. Jobs Report in Focus
Motley Fool
Why Moderna Stock Blasted 13% Higher Today
Barchart
Strength in Chips Stocks Leads the Overall Market Higher
Motley Fool
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Barchart
Stocks Rebound Ahead of Apple’s Earnings
The Globe and Mail
Market movers: Stocks seeing action on Thursday - and why
Newswire.ca
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
BayStreet.ca
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses
Barchart
2 Penny Stocks That Wall Street Predicts Will Soar Over 300%
Motley Fool
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Motley Fool
Should You Buy Moderna Before May 12?
ACCESSWIRE
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Motley Fool
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool
2 Stocks Down 30% to Buy Right Now
Motley Fool
1 New Green Flag for Moderna and Merck Stock
Barchart
Stock Indexes Plummet After U.S. Inflation Data Released
Barchart
Stocks Rebound as Bond Yields Fall Ahead of Wednesday’s US CPI Report
Barchart
Stocks Retreat on Risk Aversion Ahead of Wednesday’s US CPI Report
Motley Fool
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Motley Fool
Is Moderna Stock Going to $214? 1 Wall Street Analyst Thinks So.
Motley Fool
2 Stocks Down 30% and 27% to Buy and Hold
Motley Fool
Moderna Stock: Buy, Sell, or Hold?
Motley Fool
Better Recovery Story Buy: Pfizer vs Moderna
Motley Fool
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
Motley Fool
Better Cathie Wood Stock: Moderna vs. Intellia
Barchart
Stocks End Lower as Hawkish Fed Comments Push Bond Yields Higher
Barchart
Stocks Slip on Corporate News and Hawkish Fed Comments
Barchart
Negative Corporate News Undercuts Stocks
Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
Motley Fool
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks

Profile

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency use in several countries as COVID-19 vaccine. The company has also developed booster doses of its COVID-19 vaccine and is developing variant-specific booster candidates.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.